Search Results - Segreti, A.C

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    P.3.d.018 Phase 2 clinical trial of TC-5619, an alpha 7 nicotinic receptor agonist in the treatment of negative and cognitive symptoms in schizophrenia

    P.3.d.018 Phase 2 clinical trial of TC-5619, an alpha 7 nicotinic receptor agonist in the treatment of negative and cognitive symptoms in schizophrenia by Hosford, D, Dvergsten, C, Beaver, J, Segreti, A.C, Toler, S, Farr, M.G, Joseph, M, Jett, J, Lippiello, P, Bencherif, M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: